Your browser doesn't support javascript.
loading
Anti-Xa assays: What is their role today in antithrombotic therapy?
Hutt Centeno, Erika; Militello, Michael; Gomes, Marcelo P.
Affiliation
  • Hutt Centeno E; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA. huttcee@ccf.org.
  • Militello M; Clinical Instructor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
  • Gomes MP; Medical Operations, Inpatient Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
Cleve Clin J Med ; 86(6): 417-425, 2019 Jun.
Article in En | MEDLINE | ID: mdl-31204981
ABSTRACT
Although some suggest anti-Xa assays should be the preferred method for monitoring intravenous unfractionated heparin therapy, which method is best is unknown owing to the lack of large randomized controlled trials correlating different assays with clinical outcomes. This article provides an overview of heparin monitoring and the pros, cons, and clinical applications of anti-Xa assays.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Tests / Heparin / Drug Monitoring / Fibrinolytic Agents / Antifibrinolytic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Cleve Clin J Med Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Tests / Heparin / Drug Monitoring / Fibrinolytic Agents / Antifibrinolytic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Cleve Clin J Med Year: 2019 Document type: Article